SFTPD and adenocarcinoma: Furthermore, with the help of a TRAMP (transgenic adenocarcinoma of mouse prostate) model, increased degradation of SP-D (suspectedly via serine proteases synthesised by granulocytes and polymorphonuclear myeloid-derived suppressor cells) in advanced disease stage was evidenced [58].